88% is just a near term valuation. They suggest much higher. I am also rather impressed by their conservative analysis approach with their 48 month total scenario time. Based recent information from the company, I have indicated I think we are 12-24 months out from some real big, very big upward price movements well beyond 10/share. Your 8000+% could easily happen within their total 48 month time horizon.
I think NNVC is also correct about the timeline once in human trials to be shorter than typical drug investigation phases. I don't think the report has that factored in too much.
Best of luck to all NNVC longs. You are all some of the nicest and respectable persons I have found on any internet message board.